Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AT9283

AT9283 is a multi-targeted kinase inhibitor with potent activity against Aurora A/B, JAK2/3, Abl (T315I) and Flt3 (IC50s ranging from 1 to 30 nM) . AT9283 inhibits growth and survival of multiple solid tumors in vitro and in vivo[1][2].

Product Specifications

CAS Number

[896466-04-9]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Aurora Kinase; Autophagy; Bcr-Abl; FLT3; JAK

Type

Reference compound

Related Pathways

Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/at9283.html

Purity

99.70

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C(NC1CC1)NC2=CNN=C2C3=NC4=CC=C(C=C4N3)CN5CCOCC5

Molecular Formula

C19H23N7O2

Molecular Weight

381.43

Precautions

H302, H315, H319, H335

References & Citations

[1]Howard S, et al. Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity. Journal of Medicinal Chemistry (2009), 52 (2), 379-388.|[2]Qi W, et al. AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. Int J Cancer. 2012 Jun 15;130 (12) :2997-3005.|[3]Santo L, et al. Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide. Clin Cancer Res. 2011 May 15;17 (10) :3259-71

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Isoform

Abl; Aurora A; Aurora B; JAK2; JAK3

Citation 01

BioRxiv. 2025 February 21.|Cancers (Basel) . 2022 Mar 19;14 (6) :1575.|Harvard Medical School LINCS LIBRARY|J Adv Res. 2024 Feb:56:1-14.|Patent. US20180263995A1.|PLoS One. 2024 Nov 1;19 (11) :e0308647.|Sci Transl Med. 2018 Jul 18;10 (450) :eaaq1093.|University of Washington. 2025.|Front Oncol. 2021 Jun 18:11:656608.|PLoS Pathog. 2022 Jun 13;18 (6) :e1010620.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

2010007H12Rik-set siRNA/shRNA/RNAi Lentivector (Mouse)
52064094 4x 500 ng

2010007H12Rik-set siRNA/shRNA/RNAi Lentivector (Mouse)

Ask
View Details
CCDC124 (NM_001136203) Human Tagged Lenti ORF Clone
RC227128L4 10 µg

CCDC124 (NM_001136203) Human Tagged Lenti ORF Clone

Ask
View Details
RFP-Expressing Human Bone Marrow-Derived Mesenchymal Stem Cells
RFP9 1ml frozen Vial

RFP-Expressing Human Bone Marrow-Derived Mesenchymal Stem Cells

Ask
View Details
Mouse FKBPL (FK506 Binding Protein Like Protein) ELISA Kit
EK247442 96 Well

Mouse FKBPL (FK506 Binding Protein Like Protein) ELISA Kit

Ask
View Details
SERPINA5 Polyclonal Antibody
E-AB-14445-01 20 µL

SERPINA5 Polyclonal Antibody

Ask
View Details
SERPINA5 Polyclonal Antibody
E-AB-14445-02 60 μL

SERPINA5 Polyclonal Antibody

Ask
View Details